New grad roles at Braveheart Bio
Braveheart Bio is a clinical-stage biopharmaceutical company developing therapies for hypertrophic cardiomyopathy and other serious cardiovascular diseases. Its lead candidate, BHB-1893, is an oral small-molecule cardiac myosin inhibitor in late-stage clinical development.
- Industry
- Biotech & Pharma, Healthcare & Health Tech
- Company size
- 11–50 employees
- Stage
- Public
- Open roles
- 6
No current roles
Check back soon.
Get new Braveheart Bio new grad roles by email
Free account. Get new Braveheart Bio new grad roles by email or push the minute they post.
